NGL FINE-CHEM LTD.

NSE : NGLFINEBSE : 524774ISIN CODE : INE887E01022Industry : Pharmaceuticals & DrugsHouse : Private
BSE2090.10-12.25 (-0.58 %)
PREV CLOSE ( ) 2102.35
OPEN PRICE ( ) 2106.45
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 583
TODAY'S LOW / HIGH ( )2068.60 2109.05
52 WK LOW / HIGH ( )1171 2425.1
NSE2094.00-15.65 (-0.74 %)
PREV CLOSE( ) 2109.65
OPEN PRICE ( ) 2149.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 5063
TODAY'S LOW / HIGH( ) 2080.00 2166.45
52 WK LOW / HIGH ( )1177.55 2439.95
BSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 1981
Management Info
- Chairman Rahul J Nachane - Managing Director
Registered Office

Address 301 E Square,Subhash Road,Vile Parle (East),
Mumbai,
Maharashtra-400057

Phone 022 26636450

Email info@nglfinechem.com

Website www.nglfinechem.com

Registrars Details
Purva Shareregistry (India) Pvt Ltd
Gala No 9,Shiv Shakti, Industrial Estate,Sitaram Mill Comp.,J R Boricha Marg, Lower Parel [E],Mumbai
Listing : BSE, NSE
NEWS
19Mar Appointment of Director
Inter alia, approved:- 1) Appointment of Mr. Dhananjay Mungale (DIN: 00..
19Mar Notice of Postal Ballot
Inter alia, approved:- 1) Appointment of Mr. Dhananjay Mungale (DIN: 00..
19Mar NGL Fine-Chem submits postal ballot no
With reference to its earlier announcement dated March 18, 2024, wherein..
11Mar NGL Fine-Chem informs about board meet
NGL Fine-Chem has informed that the fifth Board Meeting for the financia..
11Mar Appointment of Director
Inter alia to consider and approve: (1) Appointment of Mr. Dhananjay Mu..
Financials
Rs. in Millions
QTR Dec 23 ANNUAL 23
Net Profit88.96201.19
Gross Profit 127.96 266
Operating Profit 151.38356.96
Net Sales 848.122750.52
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Abbott India (BSE)
 26946.00 (0.74%)
M.Cap (Rs. in Cr)57258.37
Sanofi India (BSE)
 8118.25 (2.06%)
M.Cap (Rs. in Cr)18696.83
Dr. Reddy's Lab (BSE)
 6155.15 (1.78%)
M.Cap (Rs. in Cr)102679.14
Divi's Lab (BSE)
 3436.75 (2.14%)
M.Cap (Rs. in Cr)91234.91
Glaxosmithkline Phar (BSE)
 1943.10 (3.26%)
M.Cap (Rs. in Cr)32917.29
Shareholding Pattern
PROMOTERS 73.06%
NON-INSTITUTION 26.9%
MUTUAL FUNDS/UTI 0%
FI/BANKS/INSURANCE 0%
GOVERNMENT 0%
FII 0%
Mf Holdings
Scheme NameHold(%)
Motilal Oswal S&P B...0.04
ATTENTION INVESTORSKYCIPO
Download Client Registration Documents (Rights & Obligations, Risk Disclosure Document, Do’s & Don’t’s) in Vernacular Language :
REGISTRATION NOS.

NSE CM-INZ000234235|NSE F& O - INZ000234235, NSE CD-INZ000234235, BSE CM–INZ000234235 |BSE F & O - INZ000234235|BSE CD- INZ000234235 MCX-SX CM-INZ000234235|MCX-SX F & O - INZ000234235|MCX-SX CD-INZ000234235 NSDL - IN-DP-NSDL-319-2009ROC REG - 21-097912,CDSL : IN-DP-242-2016|SEBI-PMS: INP000007100|LEI- 3358007DLCFNHY8J2F96

Filing compliant on SCORES – Easy & quick

  • Register on SCORES portal
  • Mandatory details for filing complaints on SCORES:
    • Name
    • PAN
    • Address
    • Mobile Number
    • E-mail ID
  • Benefits:
    • i.) Effective communication
    • ii.) Speedy redressal of the grievances
INVESTOR PROTECTION

Compliance officer : Apurva Mittal, Tel No: 022-40790035,022-40790024, Mobile No: 9152943075, E-mail ID: compliance@nnmsecurities.com, cdsl@nnmsecurities.com

Investor grievance : support@nnmsecurities.com

"NNM Securities has partnered with TradingView for its charting technology. An investment and trading platform empowering users with global market data and analytical tools like Stock Screener and Economic Calendar."

Copyright © 2021 NNM Securities.com

Advanced Charts Technology Partner: TradingView

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.